Silverarc Capital Management LLC compró acciones de Scholar Rock Holding Co. Silverarc Capital Management LLC purchased shares of Scholar Rock Holding Co.

Silverarc Capital Management LLC compró 9.711 acciones de Scholar Rock Holding Co. (NASDAQ:SRRK) por una inversión de 69.000 dólares en el tercer trimestre. Silverarc Capital Management LLC purchased 9,711 shares of Scholar Rock Holding Co. (NASDAQ:SRRK) for a $69,000 investment in Q3. Otros inversores, como el Royal Bank of Canada y el Amalgamated Bank, también aumentaron sus participaciones en SRRK. Other investors, such as Royal Bank of Canada and Amalgamated Bank, also increased their stakes in SRRK. Silverarc tiene participaciones en varias empresas de biotecnología, incluidas Evogene, Roivant Sciences, Karyopharm Therapeutics, Aerovate Therapeutics y Viridian Therapeutics. Silverarc has holdings in various biotech companies, including Evogene, Roivant Sciences, Karyopharm Therapeutics, Aerovate Therapeutics, and Viridian Therapeutics.